Evidence map›Paper›PMID 22829581›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2012

GLP-2 receptor in POMC neurons suppresses feeding behavior and gastric motility.

Xinfu Guan, Xuemei Shi, Xiaojie Li, Benny Chang, Yi Wang, Depei Li, Lawrence Chan

Abstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. GLP-2 regulation of intestinal lipid handling.Frontiers in physiology · 2024
    Review
  13. Review
  14. Intestinal Enteroendocrine Cells: Present and Future Druggable Targets.International journal of molecular sciences · 2023
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Xinfu GuanDepartment of Pediatrics, US Department of Agriculture/Agricultural Research Service Children’s Nutrition Research Center, TX 77030, USA. xguan@bcm.edu
Xuemei Shi
Xiaojie Li
Benny Chang
Yi Wang
Depei Li
Lawrence Chan
Baylor College of Medicine · USAgricultural Research Service · USThe University of Texas MD Anderson Cancer Center · USUnited States Department of Agriculture · US

Funding

Diabetes Endocrinology Research CenterP30DK079638 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI CHAN, LAWRENCE · 2008 to 2012
$6.4M
MODELS FOR ATHEROSCLEROSIS RESEARCHR01HL051586 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI CHAN, LAWRENCE · 1994 to 2014
$5.5M
Physiological role of GLP-2 receptor in the mouse intestinal growth and functionK01DK075489 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI GUAN, XINFU · 2006 to 2009
$562k
Physiological Role of CNS GLP-2 Receptor in Energy HomeostasisR03DK084125 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI GUAN, XINFU · 2009 to 2010
$136k
NHLBI NIH HHS R01 HL051586NIDDK NIH HHS DK-075489NIDDK NIH HHS DK-084125NIDDK NIH HHS K01 DK075489NIDDK NIH HHS P30 DK-079638NIDDK NIH HHS R03 DK084125
6 · The paper itself

Abstract

Glucagon-like peptides (GLP-1/2) are cosecreted from endocrine L cells in the gut and preproglucagonergic neurons in the brain. Peripheral GLP-2 action is essential for maintaining intestinal homeostasis, improving absorption efficiency and blood flow, promoting immune defense, and producing efficacy in treatment of gastrointestinal diseases. However, it is unknown if CNS GLP-2 plays a physiological role in the control of energy homeostasis. Since GLP-1/2 are cotranslated from preproglucagongene and coproduced by prohormone convertase-1, it is challenging to knockout GLP-2 only. Instead, our laboratory has generated a Glp2r-floxed mouse line to dissect cell-specific GLP-2 receptor GLP-2R) action in the regulation of energy balance. Our objective was to determine if GLP-2R in the hypothalamus modulates feeding behavior and gastric emptying. We show that Glp2r mRNA and protein are highly expressed in the arcuate nucleus and dorsomedial nucleus of the mouse hypothalamus. Using the Cre-LoxP system, we generated mice that lack Glp2r expression in POMC neurons (KO; mainly in the hypothalamus). The KO mice showed hyperphagic behavior (such as increases in food intake and meal frequency), accelerated gastric emptying (assessed by [(13)C]octanoic acid breath test), and late-onset obesity, yet there was no decrease in basal metabolic rate. Infusion of GLP-2 (2.5 nmol into the 4th ventricle) suppressed food intake and gastric emptying, while GLP-2-mediated effects were abolished in the melanocortin receptor-4 (MC4R) KO mice. We conclude that Glp2r deletion in POMC neurons enhances feeding behavior and gastric motility, whereas icv GLP-2R activation suppresses food intake and gastric emptying through the MC4R signaling pathway. This study indicates that CNS GLP-2R plays a physiological role in the control of feeding behavior and gastric emptying and that this is mediated probably through the melanocortin system.

Indexed as

AnimalsArcuate Nucleus of HypothalamusDorsomedial Hypothalamic NucleusFeeding BehaviorFemaleGastrointestinal MotilityGlucagon-Like Peptide 2Glucagon-Like Peptide-2 ReceptorMaleMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicNeuronsPro-OpiomelanocortinReceptor, Melanocortin, Type 4Glucagon-Like Peptide 2Glucagon-Like Peptide-2 ReceptorMC4R protein, mousePro-OpiomelanocortinReceptor, Melanocortin, Type 4Receptors, Glucagon

Identifiers

PMID22829581
PMCPMC3469617
OpenAlexW2157637610

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.